Elise Vene
Overview
Explore the profile of Elise Vene including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Foucault-Fruchard L, Michelet-Barbotin V, Leichnam A, Tching-Sin M, Nizet P, Tollec S, et al.
BMC Med Educ
. 2024 Dec;
24(1):1435.
PMID: 39696320
Background: Effective communication in healthcare, among professionals and between professionals and patients is crucial for delivering high-quality care. While simulation effectively translates technical skills to clinical practice, its impact on...
2.
Huon J, Nizet P, Tollec S, Vene E, Fronteau C, Leichnam A, et al.
Int J Clin Pharm
. 2024 Apr;
46(4):795-810.
PMID: 38632204
Background: Although confidence does not automatically imply competence, it does provide pharmacy students with a sense of empowerment to manage a pharmacotherapeutic problem independently. Among the methods used in higher...
3.
Brossard C, Vlach M, Jacquet L, Vene E, Dorcet V, Loyer P, et al.
Polymers (Basel)
. 2022 Jun;
14(12).
PMID: 35746020
We recently demonstrated the strong tropism of George Baker (GB) Virus A (GBVA10-9) and protein (CPB) derived synthetic peptides towards hepatoma cells. In a first approach, these peptides were covalently...
4.
Vene E, Jarnouen K, Ribault C, Vlach M, Verres Y, Bourgeois M, et al.
Pharmaceutics
. 2022 Apr;
14(4).
PMID: 35456637
In order to identify the peptides, selected from the literature, that exhibit the strongest tropism towards human hepatoma cells, cell uptake assays were performed using biotinylated synthetic peptides bound to...
5.
Brossard C, Vlach M, Vene E, Ribault C, Dorcet V, Noiret N, et al.
Nanomaterials (Basel)
. 2021 Apr;
11(4).
PMID: 33918663
Recently, short synthetic peptides have gained interest as targeting agents in the design of site-specific nanomedicines. In this context, our work aimed at developing new tools for the diagnosis and/or...
6.
Oliveira da Silva C, Gicquel T, Daniel Y, Bartholo T, Vene E, Loyer P, et al.
Sci Rep
. 2020 Aug;
10(1):12796.
PMID: 32732964
Cigarette smoke exposure (CS) is the main risk factor for chronic obstructive pulmonary disease (COPD). Macrophages have an important role in COPD because they release pro-inflammatory and anti-inflammatory cytokines. The...
7.
Hugbart C, Verres Y, Le Dare B, Bucher S, Vene E, Bodin A, et al.
Toxicol In Vitro
. 2020 Apr;
66:104842.
PMID: 32283135
Ethanol is the most frequently psychoactive substance used in the world, leading to major public health problems with several millions of deaths attributed to alcohol consumption each year. Metabolism of...
8.
Casajus H, Saba S, Vlach M, Vene E, Ribault C, Tranchimand S, et al.
Polymers (Basel)
. 2019 Apr;
10(11).
PMID: 30961169
The design of drug-loaded nanoparticles (NPs) appears to be a suitable strategy for the prolonged plasma concentration of therapeutic payloads, higher bioavailability, and the reduction of side effects compared with...
9.
Le Dare B, Victoni T, Bodin A, Vlach M, Vene E, Loyer P, et al.
Fundam Clin Pharmacol
. 2018 Nov;
33(1):63-74.
PMID: 30447168
Alcohol consumption is considered to be the third leading cause of death in the United States. In addition to its direct toxicity, ethanol has two contrasting effects on the immune...
10.
Quesnot N, Bucher S, Gade C, Vlach M, Vene E, Valenca S, et al.
Arch Toxicol
. 2018 Aug;
92(10):3077-3091.
PMID: 30151596
CYP2E1 activity is measured in vitro and in vivo via hydroxylation of the Chlorzoxazone (CHZ) producing the 6-hydroxychlorzoxazone (OH-CHZ) further metabolized as a glucuronide excreted in urine. Thus, the quantification...